Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer

SIMPLE SUMMARY: Using a first-principles approach, we demonstrate how standard-of-care therapies for bone metastatic prostate cancer (BMPCa) patients can be optimized with the use of routine measurements to significantly delay the evolution of resistant disease, potentially extending overall patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Araujo, Arturo, Cook, Leah M., Frieling, Jeremy S., Tan, Winston, Copland, John A., Kohli, Manish, Gupta, Shilpa, Dhillon, Jasreman, Pow-Sang, Julio, Lynch, Conor C., Basanta, David
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7915310/
https://ncbi.nlm.nih.gov/pubmed/33567529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040677
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars